Osteoarthritis

Global osteoarthritis prevalence increased more than 113% between 1990 and 2019, with the most cases appearing in China, India and the United States, according to data published in Arthritis & Rheumatology.

Patients with knee osteoarthritis who undergo arthroscopic partial meniscectomy experience “heightened” progression in osteophytes, cartilage surface area and effusion-synovitis from baseline to 18 months, according to data.

Since the FDA approved reverse shoulder arthroplasty in 2004, the orthopedic world has become enamored with this technology.

Bicompartmental knee arthroplasty is one of the hottest topics in knee replacement surgery.

In patients with or at risk for knee osteoarthritis, older age is strongly associated a three-to-fivefold increase in prevalent radiographic hand OA, compared with younger ages, with significant age, sex and race interactions, according to data.

A personalized referral system dubbed Support and Treatment After Replacement, or STAR, is cost effective and improves chronic pain after total knee replacement over a 1-year period, according to data published in The Lancet Rheumatology.

Although initially more expensive, a physical therapy course for knee osteoarthritis is more cost-effective after 1 year than a course of glucocorticoid injections, according to data published in JAMA Network Open.

Adding duloxetine to usual care fails to result in any “clinically relevant effect” in patients with chronic hip or knee osteoarthritis pain, compared with usual care alone, according to data published in Arthritis & Rheumatology.

The burden of hip osteoarthritis has increased globally in the past 30 years, with incidence and disability-adjusted life years rising “in nearly all countries,” according to data published in Arthritis Research & Therapy.

As many as 9% of Medicare beneficiaries with knee osteoarthritis use opioids chronically, while 21% are occasional users, according to data published in Arthritis Care & Research.